Clinical Trial

Treatment of ELectroencephalographic STatus Epilepticus After Cardiopulmonary Resuscitation-2 (TELSTAR-2)

Study acronym: TELSTAR-2
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this comparative effectiveness trial is to study electrographic status epilepticus (ESE) treatment in comatose patients after cardiac arrest. The main questions the trial aims to answer are: * Does ESE treatment improve outcome? * What is the impact of ESE treatment on healthcare costs? Participants in the the intervention group will receive standard care completed with anti-seizure treatment. The control group will receive standard care without anti-seizure treatment.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-08-07; most recent amendment 2026-07-03.
Status change: Not Yet Recruiting → Recruiting 2025-05-13
Trial Details
NCT Number NCT06549426
Lead Sponsor University of Twente
Collaborators: Erasme University Hospital, ZonMw: The Netherlands Organisation for Health Research and Development, Belgium Health Care Knowledge Centre
Conditions Coma, Electrographic Status Epilepticus
Enrollment 150 participants
Start Date 2025-04-10
Primary Completion 2029-12 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-07